In a small subgroup of 11 APOE-ADH/FCHL unrelated probands, including five p.Leu167del carriers, we report a significantly greater fold-reduction of LDL-C than estimated for FH patients who present ADH due to a mutation within the LDLR gene (Table 3). The gene discussed is APOE; the disease is familial hyperaldosteronism.